Genpharmasec Ltd. - Research Center
531592 GENPHARMA Group (XT) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 24 |
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sales |
11.07 |
13.82 |
12.89 |
14.20 |
13.12 |
Operating profit |
0.49 |
-0.02 |
-0.17 |
0.01 |
-0.53 |
Interest |
0.11 |
0.13 |
- |
- |
- |
Gross profit |
1.81 |
0.12 |
-0.14 |
0.03 |
-0.46 |
EPS (Rs) |
0.03 |
- |
-0.01 |
0.01 |
-0.02 |
Half yearly
results in details
|
Sep ' 24 |
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Other income |
1.44 |
0.26 |
0.02 |
0.03 |
0.07 |
Stock adjustment |
-1.78 |
-0.71 |
2.64 |
0.09 |
-2.29 |
Raw material |
- |
- |
- |
- |
- |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.31 |
0.37 |
0.18 |
0.15 |
0.10 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
12.06 |
14.18 |
10.24 |
13.95 |
15.84 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.05 |
0.01 |
0.01 |
0.01 |
0.01 |
Taxation |
0.18 |
0.08 |
- |
-0.23 |
- |
Net profit / loss |
1.59 |
0.03 |
-0.15 |
0.26 |
-0.47 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
55.37 |
27.69 |
27.69 |
27.69 |
27.69 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
4.39 |
-0.13 |
-1.28 |
0.05 |
-4.03 |
GPM (%) |
14.48 |
.84 |
-1.10 |
.24 |
-3.51 |
NPM (%) |
12.68 |
0.24 |
-1.16 |
1.83 |
-3.56 |